Patents by Inventor Sumaira Umbreen

Sumaira Umbreen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL HETERO-DIELS-ALDER CROSS-LINKER AND USE THEREOF IN REVERSIBLY CROSSLINKED POLYMER SYSTEMS
    Publication number: 20190016676
    Abstract: The invention relates to a novel hetero-Diels-Alder crosslinker, to a process for the production thereof and to the use thereof for reversibly crosslinking polymer systems.
    Type: Application
    Filed: January 20, 2017
    Publication date: January 17, 2019
    Applicant: Evonik Degussa GmbH
    Inventors: Friedrich Georg SCHMIDT, Uwe PAULMANN, Christian RICHTER, Marcel INHESTERN, Christian MEIER, Christopher BARNER-KOWOLLIK, Kai PAHNKE, Miguel Angel SANZ, Sumaira UMBREEN, Christian Ewald JANSSEN
  • Mimetic peptides and the use thereof in the form of 20S, 26S and immunoproteasome inhibitors
    Patent number: 8835392
    Abstract: The present invention relates to peptide-mimetic compounds, the synthesis and use thereof fort he inhibition of proteasomes and the induction of apoptosis in tumor cells. The present invention furthermore relates to pharmaceutical compositions comprising the compounds and the use of the compounds for a treatment of diseases, in particular cancer and neurodegenerative diseases.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: September 16, 2014
    Assignees: Technische Universität, Charité—Universitätsmedizin Berlin
    Inventors: Boris Schmidt, Sumaira Umbreen, Hannes Braun, Peter-Michael Kloetzel, Ulrike Kuckelkorn
  • Mimetic Peptides and the Use Thereof in the Form of 20S, 26S and Immunoproteasome Inhitibors
    Publication number: 20090012007
    Abstract: The present invention relates to peptide-mimetic compounds, the synthesis and use thereof fort he inhibition of proteasomes and the induction of apoptosis in tumour cells. The present invention furthermore relates to pharmaceutical compositions comprising the compounds and the use of the compounds for a treatment of diseases, in particular cancer and neurodegenerative diseases.
    Type: Application
    Filed: March 3, 2006
    Publication date: January 8, 2009
    Inventors: Boris Schmidt, Sumaira Umbreen, Hannes Braun, Peter-Michael Kloetzel, Ulrike Kuckelkorn